Healthcare -
Biotechnology - NASDAQ - US
$ 37.35
2.38 %
$ 3.46 B
Market Cap
-10.09
P/E
CRNX - RESEARCH & DEVELOPMENT
Research & Development CRNX - Crinetics Pharmaceuticals, Inc.
169 M
LAST VALUE
41.43%
2 YEAR CAGR
47.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR